Phase 4 Osteoporosis Clinical Trials
29 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–20 of 29 trials
Recruiting
Phase 4
Combined Anabolic Therapy
OsteoporosisOsteoporosis, Postmenopausal
Massachusetts General Hospital50 enrolled1 locationNCT06558188
Recruiting
Phase 4
GLP-1R Actions on Muscle and the Skeleton
ObesityOsteoporosisDrug Effect+2 more
Pennington Biomedical Research Center50 enrolled1 locationNCT07154719
Recruiting
Phase 4
A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China
Glucocorticoid-induced Osteoporosis
Amgen100 enrolled16 locationsNCT06588153
Recruiting
Phase 4
Preserving Geriatric Muscle With an Osteoporosis Medication
Osteoporosis
Susan L. Greenspan155 enrolled1 locationNCT06118905
Recruiting
Phase 4
Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients
Osteoporosis
National Taiwan University Hospital70 enrolled1 locationNCT06938152
Recruiting
Phase 4
Step-down Therapy After Long-term Osteoporosis Treatment
Osteoporosis
National Taiwan University Hospital44 enrolled1 locationNCT07281586
Recruiting
Phase 4
The Effect of Denosumab on Muscle and Strength and Insulin Sensitivity
Osteoporosis
Aarhus University Hospital40 enrolled1 locationNCT07271771
Recruiting
Phase 4
Romosozumab and Denosumab, Alone or Combined, in Postmenopausal Osteoporosis
Osteoporosis
National Taiwan University Hospital90 enrolled1 locationNCT07283887
Recruiting
Phase 4
Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover
Age-Related Osteoporosis
Madhumathi Rao60 enrolled1 locationNCT05151484
Recruiting
Phase 4
A Clinical Study on the Effect of Discontinuing Alendronate in Postmenopausal Women With Osteoporosis After a Treatment Period Without Fractures
Osteoporosis in Post-menopausal Women
Odense University Hospital1,400 enrolled7 locationsNCT06864130
Not Yet Recruiting
Phase 4
A pragmatic, randomised study of treatments to prevent the acute phase response following first zoledronate infusion
Osteoporosis
University of Auckland180 enrolled1 locationACTRN12624001403527
Recruiting
Phase 4
Romosozumab Versus Denosumab in GIOP: a 2-year Extension Study
OsteoporosisGlucocorticoids Toxicity
Tuen Mun Hospital63 enrolled1 locationNCT06472050
Recruiting
Phase 4
Zoledronate Early to Hip Fracture Patients - Safe and Effective?
OsteoporosisHip Fractures
Lene Bergendal Solberg300 enrolled1 locationNCT05025293
Recruiting
Phase 4
The Optimised Use of Romozosumab Study
Osteoporosis
University of Aarhus270 enrolled1 locationNCT06059222
Recruiting
Phase 4
Investigating the effect of Romosozumab on osteoporosis following spinal cord injury
OsteoporosisAcute Spinal Cord Injury
Princess Alexandra Hospital, Metro South Health32 enrolled1 locationACTRN12623000141640
Active
Phase 4
Investigating the effect of topical testosterone cream on bone loss and sexual function in postmenopausal women: a randomized, double blind, placebo-controlled trial
OsteoporosisPrimary Ovarian InsufficiencyEarly menopause
Monash University116 enrolled3 locationsACTRN12621001100886
Not Yet Recruiting
Phase 4
Open-Label Study to Evaluate the Inter-subject Variability of Single Dose Prolia Pharmacokinetics and Pharmacodynamics, Administered by Subcutaneous Injection in Healthy Postmenopausal Women
Osteoporosis
Christchurch Clinical Studies Trust20 enrolled1 locationACTRN12621000728831
Recruiting
Phase 4
Calcium supplements and 24-hour blood pressure
Osteoporosis
Sarah Bristow50 enrolled1 locationACTRN12617000697381
Completed
Phase 4
Effect of Nitrates on Bone Density
Osteoporosis
University of Auckland240 enrolled1 locationACTRN12615001027505
Completed
Phase 4
A randomized controlled trial to assess the effect of dexamethasone on the incidence of the acute phase response following treatment with zoledronic acid
Paget's diseaseMetabolic bone diseaseOsteoporosis
Bone & Joint Research Group, University of Auckland40 enrolled1 locationACTRN12615000794505